Abstract
A new Universal rule for Covid 19 data is derived in this paper using the SIR model.
It relates infection and removal rates and is validated by the global Covid 19 data. Over 186,000 data points, from 190 countries and the states of the US, for the period April 1 to December 12, 2020 - fall on a single line, as the Universal rule predicts, transcending geography, ethnicity and race.
The Universal rule requires that Herd immunity begin when just 25% of the population is vaccinated. With the anticipated 100 million vaccinations in the first 100 days of the Biden administration, Herd immunity may be imminent in the US.
The Universal rule promotes a temporary stasis with continuing infections and hospitalizations and becomes a barrier to runaway infections, making it practically impossible to reach Herd immunity, as Sweden discovered. Reduced infected population seems to be a third option to stifle the epidemic - a little known accomplishment, first by North Dakota and subsequently by twelve other U.S. states, including South Dakota.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There was no external funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
There were no relevant ethical guidelines as the research dealt only with public and demographic global data as published by Johns Hopkins
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
“When there is Satyam and Sundaram, Shivam is sure to follow”
Data Availability
All the necessary data to reproduce the results are in an excel file that is in the supplemental files.
